First ever data demonstrating anti-leukemic effect of Actimab-A in FLT3 Mutant AML models
https://finance.yahoo.com/news/actinium-pharma-highlights-three-abstracts-110000869.html
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.